SCHEMBL10101882

SCHEMBL10101882

CC(=O)c1ccc(C)c(OC(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
TSHR P16473 2/20 0.54
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
PKM P14618 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 4/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
RORC P51449 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
PDE4B Q07343 1/20 0.41
CYP2A6 P11509 1/20 0.41
PARP10 Q53GL7 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10762377 0.86 ALDH1A1 (0.57) ALDH1A1TSHRKMT2AMEN1PKM
SCHEMBL2536664 0.86 KMT2A (0.55) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL30628216 0.86 ALDH1A1 (0.57) ALDH1A1TSHRKMT2AMEN1PKM
SCHEMBL23606802 0.84 PARP10 (0.56) ALDH1A1TSHRKMT2APOLBMAPT
SCHEMBL2827824 0.83 NOTUM (0.56) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL23739274 0.83 CA12 (0.56) ALDH1A1KMT2AMEN1MAPTNPY1R
SCHEMBL17037233 0.82 POLB (0.55) ALDH1A1TSHRKMT2AMEN1PKM
SCHEMBL10101878 0.81 PDE4B (0.47) ALDH1A1TSHRKMT2AMEN1POLB
SCHEMBL661271 0.81 ALDH1A1 (0.56) ALDH1A1TSHRKMT2AMEN1PKM
SCHEMBL26030946 0.81 RXRA (0.53) ALDH1A1TSHRKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 ALDH1A1 2237/4885TSHR 3564/4885KMT2A 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.